http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 18 Jun 2026 06:11:26 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/New+Coverage/BofA+Securities+Starts+Immix+Biopharma%2C+Inc.++%28IMMX%29+at+Buy/26662409.html (Updated - June 18, 2026 6:11 AM EDT) <p>BofA Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma, Inc. (NASDAQ: IMMX) with a Buy rating and a price target of $27.00.</p><p>The analyst comments "We initiate coverage of IMMX with a Buy rating and $27 PO. IMMX is developing NXC201 for AL amyloidosis, a rare disease with damaged vital organs and no approved treatments. Early data of NXC-201 shows ~95% complete response and rapid minimal residual disease in relapsed/refractory (r/r) AL amyloidosis. The safety profile was favorable for patients facing potential organ failure with no observed neurotoxicity. Updated phase 2 data is http://www.streetinsider.com/New+Coverage/BofA+Securities+Starts+Immix+Biopharma%2C+Inc.++%28IMMX%29+at+Buy/26662409.html Thu, 18 Jun 2026 06:11:26 -0400 IMMX http://www.streetinsider.com/Analyst+Comments/BofA+Securities+Starts+Immix+Biopharma%2C+Inc.++%28IMMX%29+at+Buy/26662409.html (Updated - June 18, 2026 6:11 AM EDT) <p>BofA Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma, Inc. (NASDAQ: IMMX) with a Buy rating and a price target of $27.00.</p><p>The analyst comments "We initiate coverage of IMMX with a Buy rating and $27 PO. IMMX is developing NXC201 for AL amyloidosis, a rare disease with damaged vital organs and no approved treatments. Early data of NXC-201 shows ~95% complete response and rapid minimal residual disease in relapsed/refractory (r/r) AL amyloidosis. The safety profile was favorable for patients facing potential organ failure with no observed neurotoxicity. Updated phase 2 data is http://www.streetinsider.com/Analyst+Comments/BofA+Securities+Starts+Immix+Biopharma%2C+Inc.++%28IMMX%29+at+Buy/26662409.html Thu, 18 Jun 2026 06:11:26 -0400 IMMX http://www.streetinsider.com/Hot+Comments/BofA+Securities+Starts+Immix+Biopharma%2C+Inc.++%28IMMX%29+at+Buy/26662409.html (Updated - June 18, 2026 6:11 AM EDT) <p>BofA Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma, Inc. (NASDAQ: IMMX) with a Buy rating and a price target of $27.00.</p><p>The analyst comments "We initiate coverage of IMMX with a Buy rating and $27 PO. IMMX is developing NXC201 for AL amyloidosis, a rare disease with damaged vital organs and no approved treatments. Early data of NXC-201 shows ~95% complete response and rapid minimal residual disease in relapsed/refractory (r/r) AL amyloidosis. The safety profile was favorable for patients facing potential organ failure with no observed neurotoxicity. Updated phase 2 data is http://www.streetinsider.com/Hot+Comments/BofA+Securities+Starts+Immix+Biopharma%2C+Inc.++%28IMMX%29+at+Buy/26662409.html Thu, 18 Jun 2026 06:11:26 -0400 IMMX http://www.streetinsider.com/Hot+New+Coverage/BofA+Securities+Starts+Immix+Biopharma%2C+Inc.++%28IMMX%29+at+Buy/26662409.html (Updated - June 18, 2026 6:11 AM EDT) <p>BofA Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma, Inc. (NASDAQ: IMMX) with a Buy rating and a price target of $27.00.</p><p>The analyst comments "We initiate coverage of IMMX with a Buy rating and $27 PO. IMMX is developing NXC201 for AL amyloidosis, a rare disease with damaged vital organs and no approved treatments. Early data of NXC-201 shows ~95% complete response and rapid minimal residual disease in relapsed/refractory (r/r) AL amyloidosis. The safety profile was favorable for patients facing potential organ failure with no observed neurotoxicity. Updated phase 2 data is http://www.streetinsider.com/Hot+New+Coverage/BofA+Securities+Starts+Immix+Biopharma%2C+Inc.++%28IMMX%29+at+Buy/26662409.html Thu, 18 Jun 2026 06:11:26 -0400 IMMX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Immix+Biopharma%2C+Inc.++++++++++++++++++Filed+by%3A+JANUS+HENDERSON+GROUP+PLC/26610062.html si-local-file:///var/storage/secattach/20260605/26610062.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Immix+Biopharma%2C+Inc.++++++++++++++++++Filed+by%3A+JANUS+HENDERSON+GROUP+PLC/26610062.html Fri, 05 Jun 2026 12:57:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Immix+Biopharma%2C+Inc.++++++++++++++++++Filed+by%3A+JANUS+HENDERSON+GROUP+PLC/26610062.html si-local-file:///var/storage/secattach/20260605/26610062.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Immix+Biopharma%2C+Inc.++++++++++++++++++Filed+by%3A+JANUS+HENDERSON+GROUP+PLC/26610062.html Fri, 05 Jun 2026 12:57:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22/26576467.html si-local-file:///var/storage/secattach/20260529/26576467.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22/26576467.html Fri, 29 May 2026 17:10:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22/26576467.html si-local-file:///var/storage/secattach/20260529/26576467.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22/26576467.html Fri, 29 May 2026 17:10:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Hsu+Jason/26576388.html si-local-file:///var/storage/secattach/20260529/26576388.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Hsu+Jason/26576388.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Hsu+Jason/26576388.html si-local-file:///var/storage/secattach/20260529/26576388.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Hsu+Jason/26576388.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Rachman+Ilya+M/26576389.html si-local-file:///var/storage/secattach/20260529/26576389.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Rachman+Ilya+M/26576389.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Rachman+Ilya+M/26576389.html si-local-file:///var/storage/secattach/20260529/26576389.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Rachman+Ilya+M/26576389.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Chudnovsky+Yekaterina/26576390.html si-local-file:///var/storage/secattach/20260529/26576390.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Chudnovsky+Yekaterina/26576390.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Chudnovsky+Yekaterina/26576390.html si-local-file:///var/storage/secattach/20260529/26576390.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Chudnovsky+Yekaterina/26576390.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+BUCHAN+JANE/26576391.html si-local-file:///var/storage/secattach/20260529/26576391.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+BUCHAN+JANE/26576391.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+BUCHAN+JANE/26576391.html si-local-file:///var/storage/secattach/20260529/26576391.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+BUCHAN+JANE/26576391.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Ng+Carey/26576396.html si-local-file:///var/storage/secattach/20260529/26576396.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Ng+Carey/26576396.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Ng+Carey/26576396.html si-local-file:///var/storage/secattach/20260529/26576396.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Ng+Carey/26576396.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+CHANG+NANCY+T/26576399.html si-local-file:///var/storage/secattach/20260529/26576399.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+CHANG+NANCY+T/26576399.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+CHANG+NANCY+T/26576399.html si-local-file:///var/storage/secattach/20260529/26576399.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+CHANG+NANCY+T/26576399.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Adams+Helen+C./26576400.html si-local-file:///var/storage/secattach/20260529/26576400.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Adams+Helen+C./26576400.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Adams+Helen+C./26576400.html si-local-file:///var/storage/secattach/20260529/26576400.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Adams+Helen+C./26576400.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Marquet+Magda/26576401.html si-local-file:///var/storage/secattach/20260529/26576401.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Marquet+Magda/26576401.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Marquet+Magda/26576401.html si-local-file:///var/storage/secattach/20260529/26576401.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Marquet+Magda/26576401.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Morris+Gabriel+S/26576402.html si-local-file:///var/storage/secattach/20260529/26576402.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Immix+Biopharma%2C+Inc.+++++For%3A+May+22++Filed+by%3A+Morris+Gabriel+S/26576402.html Fri, 29 May 2026 17:05:00 -0400 IMMX O.45981640